Functional determination of emicizumab in presence of factor VIII activity-Reference-Cited by-同舟云学术

Functional determination of emicizumab in presence of factor VIII activity

Published:2023-12 Issue:12 Volume:21 Page:3490-3500
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Hamedani Nasim Shahidi,Donners Anouk Anna Marie Therese,van Luin Matthijs,Gasper Simone,Rühl Heiko,Klein Claudia,Albert Thilo,EL Amrani Mohsin,Pötzsch Bernd,Oldenburg Johannes,Müller Jens

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. Haemophilias A and B;Bolton-Maggs;Lancet,2003

2. Acquired haemophilia A: a review of what we know;Mingot-Castellano;J Blood Med,2022

3. Asymptomatic joint bleeding and joint health in hemophilia: a review of variables, methods, and biomarkers;Gooding;J Blood Med,2021

4. Diagnosis and treatment of hemophilia;Kizilocak;Clin Adv Hematol Oncol,2019

5. Genetic risk factors for inhibitors to factors VIII and IX;Oldenburg;Haemophilia,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on the diagnosis and treatment of hemophilia in China (Version 2024);LabMed Discovery;2024-07

2. Emicizumab plasma levels after accelerated saturation in acquired haemophilia A;Haemophilia;2024-06-24

3. Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents;Seminars in Thrombosis and Hemostasis;2024-06-12

4. Effects of heat treatment on emicizumab and an alternative approach to eliminate interfering FVIII activity prior to functional analysis;Hämostaseologie;2024-02

5. Validación de un método para la cuantificación plasmática de emicizumab;Revista Hematología;2024-01-22